Magic mushrooms can ease depression resistant to other treatments, major study finds
A major randomized clinical trial indicates that psilocybin, the active compound in magic mushrooms, provides relief for treatment-resistant depression.
2 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 2 separate news trends connected to Psychedelic Therapy, spanning June 26, 2026 through August 7, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 16 article observations and 14 source signals, led by Health coverage. Use it to compare how individual events emerged, spread and changed over time.
A major randomized clinical trial indicates that psilocybin, the active compound in magic mushrooms, provides relief for treatment-resistant depression.
An 80-year-old woman with Alzheimer's has regained speech and mobility after taking psilocybin.